Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening
Saved in:
MARC
| LEADER | 00000cam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 185935811X | ||
| 003 | DE-627 | ||
| 005 | 20231206213326.0 | ||
| 007 | tu | ||
| 008 | 230912s2022 gw ||||| m 00| ||eng c | ||
| 035 | |a (DE-627)185935811X | ||
| 035 | |a (DE-599)KXP185935811X | ||
| 035 | |a (OCoLC)1396819097 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-DE-BW | ||
| 082 | 0 | 4 | |a 616.994 |q DE-101 |
| 082 | 0 | 4 | |a 610 |a 570 |q DE-101 |
| 084 | |a 33 |2 sdnb | ||
| 084 | |a 32 |2 sdnb | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Weidenauer, Katharina |d 1997- |e VerfasserIn |0 (DE-588)1302314165 |0 (DE-627)1859328474 |4 aut | |
| 245 | 1 | 0 | |a Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening |c vorgelegt von Katharina Weidenauer ; Doktorvater: Herr Prof. Dr. med. Carsten Müller-Tidow |
| 264 | 1 | |a Heidelberg |c 2022 | |
| 300 | |a 82 Blätter |b Illustrationen, Diagramme | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 502 | |b Dissertation |c Ruprecht-Karls-Universität Heidelberg |d 2023 | ||
| 546 | |a Text Englisch, Zusammenfassung in englischer und deutscher Sprache | ||
| 655 | 7 | |a Hochschulschrift |0 (DE-588)4113937-9 |0 (DE-627)105825778 |0 (DE-576)209480580 |2 gnd-content | |
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e AkademischeR BetreuerIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 dgs | |
| 710 | 2 | |a Universität Heidelberg |e Grad-verleihende Institution |0 (DE-588)2024349-2 |0 (DE-627)102161488 |0 (DE-576)191769517 |4 dgg | |
| 751 | |a Heidelberg |0 (DE-588)4023996-2 |0 (DE-627)106300814 |0 (DE-576)208952578 |4 uvp | ||
| 951 | |a BO | ||
| 992 | |a 20231005 | ||
| 993 | |a Thesis | ||
| 994 | |a 2023 | ||
| 998 | |g 1302314165 |a Weidenauer, Katharina |m 1302314165:Weidenauer, Katharina |d 50000 |d 51001 |e 50000PW1302314165 |e 51001PW1302314165 |k 0/50000/ |k 1/50000/51001/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN185935811X |e 4381415450 | ||
| BIB | |a Y | ||
| JSO | |a {"noteThesis":["Dissertation. - Ruprecht-Karls-Universität Heidelberg. - 2023"],"language":["eng"],"recId":"185935811X","type":{"bibl":"thesis"},"title":[{"title_sort":"Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening","title":"Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening"}],"name":{"displayForm":["vorgelegt von Katharina Weidenauer ; Doktorvater: Herr Prof. Dr. med. Carsten Müller-Tidow"]},"origin":[{"dateIssuedKey":"2022","publisherPlace":"Heidelberg","dateIssuedDisp":"2022"}],"corporate":[{"role":"dgg","display":"Universität Heidelberg"}],"person":[{"given":"Katharina","display":"Weidenauer, Katharina","family":"Weidenauer","role":"aut"},{"family":"Müller-Tidow","display":"Müller-Tidow, Carsten","given":"Carsten","role":"dgs"}],"id":{"eki":["185935811X"]},"physDesc":[{"noteIll":"Illustrationen, Diagramme","extent":"82 Blätter"}]} | ||
| SRT | |a WEIDENAUERIDENTIFICA2022 | ||